Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New patents describe therapeutic agents for psychiatric disorders

April 8, 2005

Interleukin-4 mediates inflammatory modulation of synaptic function in the hippocampus

April 8, 2005

Modulation of astrocytic function as an alternative approach for the treatment of schizophrenia

April 8, 2005

PET studies predict a very low abuse liability of a new antidepressant

April 8, 2005

T-817MA alleviates oxidative stress in rat cortical neurons

April 7, 2005

Acorda launches Zanaflex Capsules

April 7, 2005

Sepracor to launch Lunesta

April 7, 2005

Antipsychotic efficacy of bifeprunox mesilate

April 7, 2005

Serotonin 5-HT7 receptor as a target for depression and other psychiatric diseases

April 7, 2005

Clinical evidence for the anxiolytic effects of LY-544344

April 6, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...